Transforming community-based healthcare

through a next generation Point of Care diagnostic Platform

Lab-comparable performance at speed
Leverages testing methodologies used in lab analyser systems, enabling healthcare providers to deliver lab-comparable performance and real-time results at the point of care
Broad test menu pipeline
Integrates several technologies and sample types into a single Instrument, allowing for a continued development of a broad test menu across conditions diagnosed and managed in community-based healthcare settings
Improved economic value
Replaces multiple point of care systems with a single Platform, increasing efficiency through reduced training, equipment, maintenance and test supplies
LumiraDx’s next generation, point of care diagnostic Platform is designed to be affordable and accessible for healthcare providers globally and intends to strengthen community-based healthcare

Introducing our high sensitivity, LumiraDx Platform. A next generation point of care diagnostic system, that combines a small, portable Instrument; microfluidic Test Strip; simple, standardized workflow; and seamless, secure digital connectivity to the Cloud and hospital IT systems.

Results at your fingertips

Lab comparable results in minutes from a small sample

Explore Instrument
*Not available in US*Not available in US*Authorized by FDA under an EUA*Authorized by FDA under an EUA

On-the-spot testing

Currently offering SARS-CoV-2 Antigen and AntibodyD-Dimer and INR test capabilities, with a pipeline of over 30 tests across a range of assay technologies including enzyme, immunoassay, molecular and electrolyte assays. All carried out on one, easy to use device.

Explore Test Menu
*Authorized by FDA under an EUA
*Not available in US
*Authorized by FDA under an EUA
*Not available in US
*Not available in US

Well connected

Our latest Cloud-based technology empowers healthcare professionals with effortless data reporting, analytics, and decision support.

Explore connectivity

Our platform is designed to be affordable and accessible at the point of care

  • Emergency department
  • Primary care
  • Health clinic
  • Retail pharmacy

See all news

LumiraDx receives approval for its COVID-19 Antigen Test for use in India

Read more

LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp.

Read more

LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics

Read more
Inquire Now

BetterHealthExperiencesOutcomes

Supporting healthier lives, for individuals, communities and wider society

Enabling responsive, personal relationships between patients and care teams.

Controlling and reducing costs to help ease pressure on healthcare budgets.